Organic acid profile of isovaleric acidemia: A comprehensive metabolomics approach

Metabolomics

Volumn 9, Issue 4, 2013, Pages 765-777

  Dercksen, Marli ^a,b   Koekemoer, Gerhard ^a   Duran, Marinus ^b   Wanders, Ronald J A ^b   Mienie, Lodewyk J ^a   Reinecke, Carolus J ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

CONCA; Data pre treatment; Dietary treatment; Isovaleric acidemia; Metabolic profile; Urinary organic acids

Indexed keywords

3 HYDROXYHEXANOIC ACID; HEXANOIC ACID DERIVATIVE; ISOVALERIC ACID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CARBOHYDRATE DIET; CATABOLISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DIET THERAPY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; ISOVALERIC ACIDEMIA; METABOLIC DISORDER; METABOLOMICS; PATHOPHYSIOLOGY; PHENOTYPE; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN DIET; SCHOOL CHILD; URINALYSIS;

IVA;

EID: 84880642615     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-013-0501-5     Document Type: Article

References (50)

1. Bakker, H. D., van Gennip, A. H., Duran, M., & Wadman, S. K. (1978). Methylmalonate excretion in a pregnancy at risk for methylmalonic acidaemia. Clinica Chimica Acta, 86, 349-352.
2. Baraldi, E., Carraro, S., Giordano, G., Reniero, F., Perilongo, G., & Zacchello, F. (2009). Metabolomics: moving towards personalized medicine. Italian Journal of Pediatrics, 35, 30-34.
3. Barker, M., & Rayens, W. (2003). Partial least squares for discrimination. Journal of Chemometrics, 17, 166-173.
4. Barshop, B. A. (2004). Metabolomic approaches to mitochondrial disease: Correlation of urine organic acids. Mitochondrion, 4, 521-527.
5. Becker, R. A., Chalmers, J. M., & Wilks, A. R. (1988). The new S-language. Pacific Grove: Wadsworth & Brooks Cole.
6. Brereton, R. G. (2003). Chemometrics-data analysis for the laboratory and chemical plant. West Sussex: John Wiley & Sons Ltd.
7. Chalmers, R. A., Healy, M. J. R., Lawson, A. M., & Watts, R. W. E. (1976). Urinary organic acid in man II. Effects of individual variation on diet on the urinary excretion of acidic metabolites. Clinical Chemistry, 22, 1288-1291.
8. Chong, I. G., & Jun, C. H. (2005). Performance of some variable selection methods when multicollinearity is present. Chemometrics and Intelligent Laboratory Systems, 78, 103-112.
9. Coude, F. X., Sweetman, L., & Nyhan, W. L. (1979). Inhibition by propionyl-coenzyme A of N-acetylglutamate synthase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. Journal of Clinical Investigation, 64, 1544-1551.
10. Dercksen, M., Duran, M., Ijlst, L., Mienie, L. J., Reinecke, C. J., Ruiter, J. P. N., et al. (2012). Clinical variability of isovaleric acidimia in a genetically homogeneous population. Journal of Inherited Metabolic Diseases, 35, 1021-1029.
11. Duran, M., Schutgens, R. B. H., Ketel, A., et al. (1979). 3-Hydroxy-3-methylglutaryl coenzyme A lyase deficiency: Postnatal management following prenatal diagnosis by analysis of maternal urine. The Journal of Pediatrics, 95, 1004-1007.
12. Ellis, S. M., & Steyn, H. S. (2003). Practical significance (effect size) versus or in combination with statistical significance (p values). Management Dynamics, 12, 51-53.
13. Ensenauer, R., Vockley, J., Willard, J., et al. (2004). A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. American Journal of Human Genetics, 75, 1136-1142.
14. Guneral, F., & Bachman, C. (1994). Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clinical Chemistry, 40, 862-868.
15. Hegazi, A. G., & Abd El-Hady, F. K. (2009). Influence of honey on suppression of human low density lipoprotein (LDL) peroxidation (in vitro). Evidence-Based Complementary and Alternative Medicine, 6, 113-121.
16. Hoffman, G. F., & Feyh, P. (2002). Organic acid analysis. In N. Blau, M. Duran, & M. E. Blaskovic (Eds.), Physician's guide to the laboratory diagnosis of metabolic diseases (pp. 27-44). Berlin: Springer.
17. Johnson, R. A., & Wichern, D. W. (1998). Applied multivariate statistical analysis (4th ed.). NJ: Upper Saddle River.
18. Jolliffe, I. T. (2002). Principal component analysis (2nd ed.). New York: Springer.
19. Kell, D. B. (2004). Metabolomics and systems biology: making sense of the soup. Current Opinion in Microbiology, 7, 296-307.
20. Kell, D. B. (2007). Metabolomic biomarkers: search, discovery and validation. Expert Review of Molecular Diagnostics, 7, 329-333.
21. Knerr, I., Weinhold, N., Vockley, J., & Gibson, K. M. (2012). Advances and challenges in the treatment of branched-chain amino/keto acid metabolic defects. Journal of Inherited Metabolic Diseases, 35, 29-40.
22. Koekemoer, G., & Swanepoel, J. W. H. (2008). A semi-parametric method for transforming data to normality. Statistics and Computing, 18, 241-257.
23. Koekemoer, G., Dercksen, M., Allison, J., Santana, L., & Reinecke, C. J. (2012). Concurrent class analysis identifies discriminatory variables from metabolomics data on isovaleric acidemia. Metabolomics, 8, S17-S28.
24. Loots, D. T. (2009). Abnormal tricarboxylic acid cycle metabolites in isovaleric acidemia. Journal of Inherited Metabolic Diseases, 3, 402-411.
25. Loots, D. T., Erasmus, E., & Mienie, L. J. (2005). Identification of 19 new metabolites induced by abnormal amino acid conjugation in isovaleric acidemia. Clinical Chemistry, 51, 1510-1512.
26. Luís, P. B., Ruiter, J. P., Ijlst, L., Diogo, L., Garcia, P., de Almeida, I. T., et al. (2012). Inhibition of 3-methylcrotonyl-CoA carboxylase explains the increased excretion of 3-hydroxyisovaleric acid in valproate-treated patients. Journal of Inherited Metabolic Disease, 35, 443-449.
27. Mamas, M., Dunn, W. B., Neyses, L., & Goodacre, R. (2011). The role of metabolites and metabolomics in clinical applicable biomarkers of disease. Archives of Toxicology, 85, 5-17.
28. Morrow, D. A., & de Lemos, J. A. (2007). Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation, 115, 949-952.
29. Mukherji, M., Kershaw, N. J., Schofield, C. J., Wierzbicki, A. S., & Lloyd, M. D. (2002). Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal α-oxidation of phytanic acid. Chemistry & Biology, 9, 597-605.
30. Niwa, T., & Yamada, K. (1985). 3-Hydroxyhexanoic acid: An abnormal metabolite in urine and serum of diabetic ketoacidotic patients. Journal of Chromatography, 337, 1-7.
31. Norman, E. L., Martelo, O. J., & Denton, M. D. (1982). Cobalamin (vitamin B12) deficiency detected by urinary methylmalonic acid quantitation. Blood, 59, 1128-1131.
32. Ogura, T. & Sakamoto, Y. Application of metabolomics techniques using LC/MS and GC/MS profiling analysis of green tea leaves. SHIMADZU Corporation, application note No. 10. http://www2. shimadzu. com/applications/GCMS, LCMS/LAANCXXE011. pdf. Accessed 7 Mar 2012.
33. Pan, Z., Gu, H., Talaty, N., Chen, H., Shanaiah, N., Hainline, B. E., et al. (2007). Principal component analysis of urine metabolites detected by NMR and DESI-MS in patients with inborn errors of metabolism. Analytical and Bioanalytical Chemistry, 387, 539-549.
34. Pitt, J. J., Eggington, M., & Kahler, S. G. (2002). Comprehensive screening of urine samples for inborn errors of metabolism by electrospray tandem mass spectrometry. Clinical Chemistry, 48, 1970-1980.
35. Rasmunsen, K. (1989). Studies on methylmalonic acid in humans. I. Concentrations in serum and urinary excretion in normal subjects after feeding and during fasting, and after loading with protein, fat, sugar, isoleucine and valine. Clinical Chemistry, 35, 2271-2276.
36. Reinecke, C. J., Koekemoer, G., van der Westhuizen, F. H., et al. (2012). Metabolomics of urinary organic acids in disorders of the respiratory chain. Metabolomics, 8, 264-283.
37. Robinson, M., White, F. J., Cleary, M. A., Wraith, E., Lam, W. K., & Walter, J. H. (2000). Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet. The Journal of Pediatrics, 136, 545-547.
38. Sakata, T. (1990). Structural and stereoisometric specificity of serum-borne sugar acids related to feeding control in rats. Brain Research Bulletin, 25, 969-974.
39. Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs, K., Kinzler, K. W. E., et al. (2001). The metabolic and molecular basis of inherited disease. New York: McGraw-Hill.
40. Styczynski, M. P., Moxley, J. F., Tong, L. V., Walther, J. L., Jensen, K. L., & Stephanopoulos, G. N. (2007). Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery. Analytical Chemistry, 79, 966-973.
41. Sweetman, L., & Williams, J. C. (2001) Branched chain organic acidurias. In C. R. Scriver, A. L. Beaudet, D. Valle, W. S. Sly, B. Childs, K. Kinzler, K. W. E. (Eds.) The metabolic and molecular basis of inherited disease (pp. 2125-2163). McGraw-Hill, New York.
42. Tanaka, K., Budd, M. A., Efron, M. L., & Isselbacher, K. J. (1966). Isovaleric acidemia: a new genetic defect of the leucine metabolism. Proceedings of the National Academy of Sciences of the United States of America, 56, 236-242.
43. Tanaka, K., Ikeda, Y., Matsubara, Y., & Hyman, D. (1988). Molecular basis of isovaleric acidemia in the study of the acyl-CoA dehydrogenase family. Advanced Neurology, 48, 107-131.
44. Truscott, R. J., Malegan, D., McCairns, E., Burke, D., Hick, L., Sims, P., et al. (1981). New metabolites in isovaleric acidemia. Clinica Chimica Acta, 110, 187-203.
45. van den Berg, R. A., Hoefsloot, H. C. J., Westerhuis, J. A., Smilde, A. K., & van der Werf, M. J. (2006). Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics, 7, 141-157.
46. Vangala, S., & Tonelli, A. (2007). Biomarkers, metabonomics, and drug development: Can inborn errors of metabolism help in understanding drug toxicity? AAPS Journal, 9, E284-E297.
47. Vockley, J., & Ensenauer, R. (2006). Isovaleric acidemia: New aspects of genetic and phenotypic heterogeneity. American Journal of Medical Genetics Part C, 142C, 95-103.
48. Wanders, R. J. A., & Waterham, H. R. (2006). Biochemistry of mammalian peroxisomes revisited. Annual Review of Biochemistry, 75, 295-332.
49. Wang, Y., & van Eys, J. (1981). Nutritional significance of fructose and sugar alcohols. Annual Review of Nutrition, 1, 437-475.
50. Wold, S. (1976). Pattern recognition by means of disjoint principal component models. Pattern Recognition, 8, 127-139.